External Evaluation of Population Pharmacokinetic Models for High‐Dose Methotrexate in Adult Patients with Hematological Tumors

Documenti analoghi

• Population Pharmacokinetics and Dosing Optimization of Piperacillin in Elderly Patients with Pneumonia in the Intensive Care Unit
  di: Jing Sun, et al.
  Pubblicazione: (2025)
• Physiologically Based Pharmacokinetic Modeling of Lemborexant: Exploration of Doses for Populations with Hepatic Impairment
  di: Wanhong Wu, et al.
  Pubblicazione: (2025)
• Dried Blood Spots Sampling and Population Pharmacokinetic Modeling for Dosing Optimization of Piperacillin in Chinese Neonates
  di: Pei Li, et al.
  Pubblicazione: (2024)
• Population Pharmacokinetics and Dosing Simulations of Pentobarbital in the Pediatric Population
  di: Victoria Etges Helfer, et al.
  Pubblicazione: (2026)
• The safety profile of usage of glucagon‐like peptide‐1 receptor agonists in pregnancy: A pharmacovigilance analysis based on the Food and Drug Administration Adverse Event Reporting System
  di: Jianxing Zhou, et al.
  Pubblicazione: (2024)